Stocks Health care MYO
NYSE · Health careMyomo, Inc. (MYO)
Myomo, Inc. brought in $43.3M of revenue over the twelve months to June 30, 2026, up 6.1% from a year earlier. It posted a net loss of $14.5M. In fiscal 2025 capital spending exceeded operating cash flow by $16.3M. At June 30, 2026 it held $11.2M in cash against $11.5M of debt. Its latest periodic report to the SEC is the quarterly report (10-Q) filed on August 5, 2026.
Key facts about Myomo, Inc.
- Net worth
- Myomo, Inc. has a market value (market cap) of $50.3M at the latest share price, and shareholders' equity of $5.8M on its balance sheet at June 30, 2026. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.
- Revenue and profit
- In fiscal 2025 revenue was $40.9M (+25.7% year on year), with a net loss of $15.6M. Over the 12 months to June 30, 2026: revenue $43.3M, net loss $14.5M.
- Cash flow
- In fiscal 2025 operations used $14.5M of cash.
- Latest report
- The latest periodic report (quarterly report, 10-Q) was filed with the SEC on August 5, 2026 and covers the period to June 30, 2026. Open on SEC EDGAR
- Next earnings report
- Myomo, Inc.'s next report was expected around November 9, 2026 and is not on file with the SEC yet.
What Myomo, Inc. does
Myomo, Inc. is registered with the SEC under industry code SIC 3842 (Orthopedic, Prosthetic & Surgical Appliances & Supplies). Its shares trade on NYSE under the ticker MYO.
Revenue and profit by year
Key figures
| Fiscal year | Revenue | Net income | Diluted EPS | Free cash flow |
|---|---|---|---|---|
| 2025 | $40.9M | -$15.6M | -$0.37 | -$16.3M |
| 2024 | $32.6M | -$6.2M | -$0.16 | -$4.7M |
| 2023 | $19.2M | -$8.1M | -$0.28 | -$6.3M |
| 2022 | $15.6M | -$10.7M | -$1.52 | -$10.3M |
| 2021 | $13.9M | -$10.4M | -$1.89 | -$9.9M |
| 2020 | $7.6M | -$11.6M | -$3.67 | -$9.1M |
Earnings: every quarter and the next report date
Full financial statements: income, balance sheet and cash flow
Where MYO ranks in Health care
Latest SEC filings
What Myomo, Inc. has filed recently, newest first. Each links to the original document on SEC EDGAR.
- August 12, 2026Passive stake changed SCHEDULE 13G/A
- August 5, 2026
- August 5, 2026Quarterly report 10-Q · period to June 30, 2026Revenue rose 21% to $11.7M versus the same quarter last year; diluted EPS -$0.09 versus -$0.11.
- August 5, 2026
- June 29, 2026
- June 26, 2026
- May 28, 2026
- May 18, 2026Activist stake changed SCHEDULE 13D/A
- May 14, 2026
- May 14, 2026Additional proxy material DEFA14A
Insider trades
What the people running Myomo, Inc. did with its shares, from the Form 4 filings they must send the SEC within two business days.
Insiders sold $71.2K worth of shares in the last 90 days and bought none on the open market.
| Date | Insider | What | Shares | Value |
|---|---|---|---|---|
| September 11, 2026 | Kovelman HarryChief Medical Officer | Sold | 15,488 | $19.7K |
| September 2, 2026 | Morris Milton MayoDirector | Sold | 15,000 | $21.2K |
| August 20, 2026 | Kovelman HarryChief Medical Officer | Sold | 17,500 | $30.3K |
| August 7, 2026 | Henry David AChief Financial Officer | Received as pay | 68,644 | - |
| August 7, 2026 | Henry David AChief Financial Officer | Shares withheld for tax | 25,310 | $35.9K |
| August 7, 2026 | Gudonis Paul RChief Executive Officer, Director | Received as pay | 146,909 | - |
| August 7, 2026 | Mitchell MicahChief Commercial Officer | Received as pay | 58,409 | - |
| August 7, 2026 | Mitchell MicahChief Commercial Officer | Shares withheld for tax | 21,559 | $30.6K |
Who owns MYO
Three views from three kinds of SEC filings, each with its own date. They overlap and are not added up.
5% holders
| Holder | Of class | Filed |
|---|---|---|
| Rosalind Advisors, Inc.13G, passive with 3 related filers | 9.9% | August 12, 2026 |
| Horton Capital Partners Fund, LP13D, may seek influence with 3 related filers | 6% | May 18, 2026 |
Largest institutional holders
Positions that investment managers reported on Form 13F for the quarter ended June 30, 2026, largest first, with the change on the quarter ended March 31, 2026. Managers file 13F up to 45 days after a quarter ends. 80 managers reported a position.
| Holder | Shares | Change on quarter |
|---|---|---|
| Rosalind Advisors, Inc. | 3,637,886 | -209,386 |
| Vanguard Capital Management LLC | 1,636,570 | +492,246 |
| Aqr Capital Management LLC | 928,268 | +609,317 |
| Jefferies Financial Group Inc. | 704,275 | 0 |
| Jane Street Group, LLC | 596,352 | new |
| Clearstead Advisors, LLC | 425,609 | +9 |
| UBS Group AG | 413,679 | +101,958 |
| Geode Capital Management, LLC | 344,417 | -514,382 |
| LPL Financial LLC | 308,000 | +2,000 |
| Palumbo Wealth Management LLC | 299,776 | new |
| Millennium Management LLC | 271,294 | new |
| BlackRock, Inc. | 223,217 | -1,465,173 |
| Vanguard Fiduciary Trust Co | 207,677 | -29,575 |
| Bnp Paribas Financial Markets | 139,194 | +131,048 |
| Ieq Capital, LLC | 127,749 | +93,910 |
| Susquehanna International Group, Llp | 120,791 | +82,402 |
| XTX Topco Ltd | 110,028 | +6,933 |
| State Street Corp | 105,875 | -277,316 |
| Citadel Advisors LLC | 102,518 | new |
| Goldman Sachs Group Inc | 94,848 | -74,097 |
Insiders
10 insiders reported holding 5,984,357 shares in total, about $7.6M at the last price.
| Holder | Shares |
|---|---|
| Manko Joseph M. Jr.Director | 2,388,4792,309,775 held indirectly |
| Gudonis Paul RChief Executive Officer, Director | 1,434,679 |
| Kirk Thomas FDirector | 772,569 |
| Henry David AChief Financial Officer | 470,163 |
| Getz Heather CDirector | 210,458 |
| Morris Milton MayoDirector | 208,391 |
| Crowley Thomas Aloysius Jr.Director | 154,931479 held indirectly |
| Mitchell MicahChief Commercial Officer | 130,738 |
| Febbo William JDirector | 123,704 |
| Kovelman HarryChief Medical Officer | 90,245 |
Questions about MYO
What does Myomo, Inc. do?
Myomo, Inc. is a company in the Health care sector, listed on NYSE as MYO. Its shares trade on NYSE under the ticker MYO.
What is Myomo, Inc.'s net worth?
Myomo, Inc. has a market value (market cap) of $50.3M at the latest share price, and shareholders' equity of $5.8M on its balance sheet at June 30, 2026. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.
Is Myomo, Inc. profitable?
No. Over the twelve months to June 30, 2026 it reported a net loss of $14.5M on revenue of $43.3M.
How much revenue does Myomo, Inc. make?
Over the twelve months to June 30, 2026 Myomo, Inc. reported revenue of $43.3M. That is 6.1% more than a year earlier.
When did Myomo, Inc. last report?
Its most recent periodic report is the quarterly report (10-Q) filed on August 5, 2026. It covers the period to June 30, 2026. Its newest filing of any kind is the insider trade from September 14, 2026.
When is Myomo, Inc.'s next earnings report?
Myomo, Inc.'s next report was expected around November 9, 2026 and is not on file with the SEC yet.
Similar companies
Compare MYO with
Follow MYO
Get an email when Myomo, Inc. files with the SEC: results, executive changes, material agreements and annual reports.
Where the numbers come from
Financial figures are the values Myomo, Inc. tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.
Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.